Bristol Myers Squibbs Investigational LPA1 Antagonist Reduces Rate of Lung Function Decline in Progressi - Benzinga
BETRF Stock | USD 0.08 0.01 9.59% |
Roughly 55% of BetterLife Pharma's stockholders are presently thinking to get in. The analysis of current outlook of investing in BetterLife Pharma suggests that some traders are interested regarding BetterLife Pharma's prospects. The current market sentiment, together with BetterLife Pharma's historical and current headlines, can help investors time the market. In addition, many technical investors use BetterLife Pharma stock news signals to limit their universe of possible portfolio assets.
BetterLife Pharma otc stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of BetterLife daily returns and investor perception about the current price of BetterLife Pharma as well as its diversification or hedging effects on your existing portfolios.
BetterLife |
ist Reduces Rate of Lung Function Decline in Progressi Benzinga
Read at news.google.com
BetterLife Pharma Fundamental Analysis
We analyze BetterLife Pharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BetterLife Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BetterLife Pharma based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Beta
Beta Comparative Analysis
BetterLife Pharma is currently under evaluation in beta category among its peers. Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
BetterLife Pharma Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with BetterLife Pharma otc stock to make a market-neutral strategy. Peer analysis of BetterLife Pharma could also be used in its relative valuation, which is a method of valuing BetterLife Pharma by comparing valuation metrics with similar companies.
Peers
BetterLife Pharma Related Equities
CVALF | Covalon Technologies | 3.83 | ||||
CMVLF | Cellectis | 0.00 | ||||
CPMV | Mosaic Immunoengineerin | 40.00 |
Complementary Tools for BetterLife OTC Stock analysis
When running BetterLife Pharma's price analysis, check to measure BetterLife Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BetterLife Pharma is operating at the current time. Most of BetterLife Pharma's value examination focuses on studying past and present price action to predict the probability of BetterLife Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BetterLife Pharma's price. Additionally, you may evaluate how the addition of BetterLife Pharma to your portfolios can decrease your overall portfolio volatility.
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Transaction History View history of all your transactions and understand their impact on performance | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |